Manufacturing Committee

The focus of the Manufacturing Committee is to build relationships between biopharmaceutical manufacturing professionals through peer-to-peer collaboration via BioNJ Membership, and to educate and inform the New Jersey life sciences community on all aspects of the manufacturing of biopharmaceuticals to facilitate scientific and medical advancement. Committee members participate in planning an annual Manufacturing Briefing.

Committee Members

Aprecia Pharmaceuticals, LLC – Jae Yoo, MBA, Ph.D., Chief Technology Officer
Chemical & Pharmaceutical Solutions – James Bruno, MBA, Ph.D., Managing Director
Hovione, LLC – Marco Marques, MBA, Ph.D., Director of Technical Operations
IVERIC bio, Inc. – Keith Westby, MBA, MSc, COO
McKinsey & Company – Andrea Gennari, Partner
McKinsey & Company – Katie Kelleher, MBA, Associate Partner
New Jersey Institute of Innovation (NJII) – Haro Hartounian, Ph.D., Senior Executive Director
Novartis Pharmaceutical – Ariel Alon, MSc, Vice President, Americas & Special Technologies
Patheon (Fisher) – Franco Negron, President, Commercial Operations, Pharma Services
PendoTECH – Jim Furey, President & CEO
Pepper Hamilton LLP – Tim Atkins, JD, Partner
Reed Smith LLP – Betty Yan, MBA, JD, Partner
Regional Personnel Services – James Lynch, President & CEO
Rutgers, The State University of New Jersey – Doug Hausner, Ph.D., Associate Director for Industrial Relations & Business Development
Rutgers, The State University of New Jersey – Fernando Muzzio, Ph.D., Director, NSF ERC on Structured Organic Systems
Rutgers, The State University of New Jersey – Vincent Smeraglia, JD, Executive Director, Office of Research Commercialization
Thermo Fisher Scientific – Mark Maxwell, Senior Business Development Executive, Pharma Services – Biologics
Ulteemit BioConsulting, LLC – Michiel Ultee, Ph.D., Principal